top
Search terms
Results 1 - 10 of 19 - ordered by :
Pages: 1 2
Ehjournal

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summaryA report of the American College of Cardiology/American Heart Association Task Force on ...

European Heart Journal, Fuster, Valentin, Rydén, Lars E., Cannom, David S., Crijns, Harry J., Curtis, Anne B., Ellenbogen, Kenneth A., Halperin, Jonathan L., Le Heuzey, Jean-Yves, Kay, G. Neal, ...

Date : 01/08/2006 Item size : 1533678 bytes
Ehjournal

Compared with patients without prior MI, these patients were more likely to be male (75 vs. 57%), on aspirin at baseline (47 vs. 34%), have prior congestive heart failure (78 vs. 59%), diabetes (47 ...

European Heart Journal, Mahaffey, Kenneth W., Stevens, Susanna R., White, Harvey D., Nessel, Christopher C., Goodman, Shaun G., Piccini, Jonathan P., Patel, Manesh R., Becker, Richard C., Halperin, ...

Date : 21/01/2014 Item size : 315201 bytes
Ehjournal

Methods and results SPORTIF III (open label, n=3410) and V (double-blind, n=3922) included 2257 women with AF and one or more stroke risk factors randomized to warfarin [target international ...

European Heart Journal, Gomberg-Maitland, Mardi, Wenger, Nanette K., Feyzi, Jan, Lengyel, Maria, Volgman, Annabelle S., Petersen, Palle, Frison, Lars, Halperin, Jonathan L.

Date : 01/08/2006 Item size : 243151 bytes
Ehjournal

Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices Methods and results We randomized 2718 ...

European Heart Journal, Martin, David T., Bersohn, Malcolm M., Waldo, Albert L., Wathen, Mark S., Choucair, Wassim K., Lip, Gregory Y.H., Ip, John, Holcomb, Richard, Akar, Joseph G., Halperin, ...

Date : 07/07/2015 Item size : 282508 bytes
Ehjournal

In the second of a two-part review, we discuss the use of NOAC for stroke prevention in the following subgroups of patients with AF: (vii) secondary stroke prevention in patients after stroke or ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017 Item size : 483367 bytes
Ehjournal

Aims We investigated clinical characteristics and outcomes of patients with significant valvular disease (SVD) in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K ...

European Heart Journal, Breithardt, Günter, Baumgartner, Helmut, Berkowitz, Scott D., Hellkamp, Anne S., Piccini, Jonathan P., Stevens, Susanna R., Lokhnygina, Yuliya, Patel, Manesh R., Halperin, ...

Date : 14/12/2014 Item size : 311347 bytes
Ehjournal

In the Rivaroxaban Once-daily oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF), rivaroxaban was shown ...

European Heart Journal, Piccini, Jonathan P., Garg, Jyotsna, Patel, Manesh R., Lokhnygina, Yuliya, Goodman, Shaun G., Becker, Richard C., Berkowitz, Scott D., Breithardt, Günter, Hacke, Werner, ...

Date : 21/07/2014
Ehjournal

See page 1427 for the editorial comment on this article (doi:10.1093/eurheartj/ehu099) Introduction Atrial fibrillation (AF) is commonly considered a progressive condition, whereby the arrhythmia ...

European Heart Journal, Nattel, Stanley, Guasch, Eduard, Savelieva, Irina, Cosio, Francisco G., Valverde, Irene, Halperin, Jonathan L., Conroy, Jennifer M., Al-Khatib, Sana M., Hess, Paul L., ...

Date : 07/06/2014
Ehjournal

In the second of a two-part review, we discuss the use of NOAC for stroke prevention in the following subgroups of patients with AF: (vii) secondary stroke prevention in patients after stroke or ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017